Pemetrexed Singlet Versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-small Cell Lung Cancer Patients with EGFR Mutations

박세훈 김범석 김세현 김기환 김유정 김진수 김태민 이세훈 김동완 이종석 허대석 2015년

연구자정보

공동연구/유사연구

논문점유율 요약
동일주제 총논문수	주제별 연구자 총논문수	연구자점유율(주제별 연구자점유율의 평균)
3,055	44	15.5%

연구자 점유율
주제		주제별 논문수	주제별 연구자논문수	주제별 연구자점유율
주제분류(KDC/DDC)	내과학	1,284	8	0.6%
주제어	opb-31121	1	1	100.0%
	stat3 inhibitor	1	1	100.0%
	targeted molecular therapy	1	1	100.0%
	phase1	2	1	50.0%
	solid tumor	3	1	33.3%
	protein kinase inhibitors	4	1	25.0%
	anaplastic lymphoma kinase	5	1	20.0%
	phase i	7	1	14.3%
	non-small cell lung carcinoma	8	1	12.5%
	epidermalgrowthfactorreceptor	25	3	12.0%
	pemetrexed	9	1	11.1%
	non-small-cell lung carcinoma	10	1	10.0%
	p-glycoprotein	10	1	10.0%
	healthcarecosts	19	1	5.3%
	nomograms	21	1	4.8%
	tyrosine kinase inhibitor	22	1	4.5%
	methotrexate	23	1	4.3%
	small cell lung carcinoma	23	1	4.3%
	hospices	26	1	3.8%
	oral	35	1	2.9%
	terminal care	34	1	2.9%
	central nervous system	42	1	2.4%
	thromboembolism	42	1	2.4%
	cisplatin	46	1	2.2%
	administration	51	1	2.0%
	platinum	51	1	2.0%
	paclitaxel	80	1	1.3%
	pharmacokinetics	80	1	1.3%
	clinical trial	82	1	1.2%
	stat3	86	1	1.2%
	lung neoplasms	117	1	0.9%
	lymphoma	113	1	0.9%
	prognosis	364	1	0.3%
	radiotherapy	328	1	0.3%
계		3,055	44
* 주제로 분류 되지 않은 논문건수			0